Using Video Images to Improve Advance Care Planning in Patients With Cancer
This study has been completed.
Information provided by (Responsible Party):
Angelo E. Volandes, MD, Massachusetts General Hospital
First received: August 6, 2009
Last updated: April 28, 2012
Last verified: April 2012
The purpose of this study is to study whether preferences for the goals of care for 80 subjects with end-stage cancer are altered after viewing a video outlining the goals of care compared to their initial preferences after hearing a verbal description of the goals of care alone.
||Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Health Services Research
||Using Video Images to Improve Advance Care Planning in Patients With Cancer
Primary Outcome Measures:
- end of life preference at time of interview [ Time Frame: 5 minutes after survey ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- knowledge [ Time Frame: 5 minutes after survey ] [ Designated as safety issue: No ]
- decisional conflict [ Time Frame: 5 minutes after survey ] [ Designated as safety issue: No ]
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||June 2011 (Final data collection date for primary outcome measure)
Experimental: Cancer subjects
outline of the goals of care
The purpose of this study is to study whether preferences for the goals of care for 80 subjects with end-stage cancer are altered after viewing a video outlining the goals of care compared to their initial preferences after hearing a verbal description of the goals of care alone. Subjects will choose among three goals of care, life prolonging care, basic medical care, and comfort care.
|Ages Eligible for Study:
||21 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Terminal, progressive cancer with poor prognosis whose treatment intent is palliative, based on the following definition:
- All patients with brain cancer, liver cancer, inoperable non-small cell lung carcinoma, pancreatic cancer, or gallbladder cancer; OR
- Patients with the following cancers: metastatic colon cancer or stage III or IV non-small cell lung cancer; OR
- Patients with the following cancers, if first-line therapy has failed and limited response is expected to second-line therapy: breast cancer, colorectal cancer, head and neck cancer, stomach cancer, esophageal cancer, melanoma, leukemia, ovarian cancer, prostate cancer, renal cancer, sarcoma, lung cancer, myeloma, or lymphoma.
- The terms terminal, progressive, poor prognosis, palliative intent and limited response will be judged by the patient's oncologist (and not by the RSA or consenting professional).
- Return patient visit (defined as a patient known to the oncologist from previous assessments and treatments, where the working and personal relationship has been established and not a new patient to the clinic).
- English speaking. Only English-speaking patients will be included in our present study since English is the validated language of our study tools.
- Given the sensitive nature of the study, clinicians will decide whether the patient is a potentially appropriate subject based on their knowledge of the patient.
- Able to provide informed consent.
- Age greater than or equal to 21.
- MMSE < 25.
- Psychological state not appropriate for end-of-life discussion as determined by the treating clinician.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00970125
|Memorial Sloan Kettering
|New York, New York, United States, 10065 |
Massachusetts General Hospital
||Angelo E. Volandes, MD, MPH
||Massachusetts General Hospital
No publications provided
||Angelo E. Volandes, MD, Faculty, Massachusetts General Hospital
History of Changes
|Other Study ID Numbers:
||2008-P-002156/2, R21 CA 139121-01
|Study First Received:
||August 6, 2009
||April 28, 2012
||United States: Institutional Review Board
Keywords provided by Massachusetts General Hospital:
advance care planning
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on December 05, 2013